Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck

European Journal of Cancer

Volumn 41, Issue 2, 2005, Pages 313-322

  Kim, Se Heon ^a   Wong, Richard J ^b   Kooby, David A ^b   Carew, John F ^b   Adusumilli, Prasad S ^b   Patel, Snehal G ^b   Shah, Jatin P ^b   Fong, Yuman ^b  

^a Yonsei University College of Medicine   (South Korea)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gene therapy; Head and neck neoplasm; Herpes simplex virus; Radiation

Indexed keywords

RECOMBINANT DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; GENE THERAPY; HEAD AND NECK CARCINOMA; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; VIRUS MUTATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GENE THERAPY; HEAD AND NECK NEOPLASMS; HERPESVIRUS 1, HUMAN; MALE; MICE; MICE, INBRED C3H; MUTATION; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; VIRUS REPLICATION;

EID: 12344314098     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.10.018     Document Type: Article

References (28)

1. H.T. Hoffman, L.H. Karnell, and G.F. Funk National cancer database report on cancer of the head and neck Arch Otolaryngol Head Neck Sur 124 1998 951 962
2. E.E. Vokes, R.R. Weichselbaum, and S.M. Lippman Head and neck cancer N Engl J Med 328 1993 184 194
3. G.L. Clayman, T.J. Liu, and M. Overholt Gene therapy for head and neck cancer: comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21) Arch Otolaryngol Head Neck Sur 122 1996 489 493
4. B.W. O'Malley, K.J. Cope, and S.H. Chen Combination gene therapy for oral cancer in a murine model Cancer Res 56 1996 1737 1741
5. S.H. Kim, J.F. Carew, and D.A. Kooby Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer Cancer Gene Ther 7 2000 1279 1285
6. J. Chou, E.R. Kern, and R.J. Whitley Mapping of herpes simplex virus-1 neurovirulence to gamma 34.5, a gene nonessential for growth in culture Science 250 1990 1262 1266
7. T. Mineta, S.D. Rabkin, and T. Yazaki Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas Nat Med 1 1995 938 943
8. B. He, J. Chou, and D.A. Liebermann The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the γ134.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells J Virol 70 1996 84 90
9. J.D. Bradley, Y. Kataoka, and S. Advani The herpes simplex virus virulence factor ICP34.5 and the cellular protein myD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34 J Virol 71 1997 9442 9449
10. M.L. Kuo, and T.J. Kinsella Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells Cancer Res 58 1998 2245 2252
11. B.W. O'Malley, K.A. Cope, and C.S. Johnson A new immunocompetentmurine model for oral cancer Arch Otolaryngol Head Neck Surg 123 1997 20 24
12. J.M. Upadhyay, J.M. Hill, and M. Jemison The effect of HSV multiplication rate on antiviral drug efficacy in vitro Antiviral Res 15 1991 67 76
13. A.I. Geller, and X.O. Breakfield A defective HSV-1 vector expresses Escherichia coli B-galactosidase in cultured peripheral neurons Science 241 1988 1667 1669
14. S. Selby Standard mathematical tables 15th ed. 1964 The Chemical Rubber Co. Cleveland, OH
15. R.J. Tallarida Drug synergism: its detection and applications J Pharmacol Exp Ther 298 2001 865 872
16. J.F. Carew, D.A. Kooby, and M.W. Halterman Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type1 (G207 Hum Gene Ther 10 1999 1599 1606
17. R.J. Wong, S.H. Kim, and J.K. Joe Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus J Am Coll Surg 193 2001 12 21
18. R.J. Wong, J.K. Joe, and S.H. Kim Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases Hum Gene Ther 13 2002 1213 1223
19. J.M. Markert, M.D. Medlock, and S.D. Rabkin Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial Gene Ther 7 2000 867 874
20. S.S. Andreansky, B. He, and G.Y. Gillespie The application of genetically engineered herpes simplex viruses to the treatment of expreimental brain tumors Proc Natl Acad Sci 93 1996 11313 11318
21. S. Andreansky, L. Soroceanu, and E.R. Flotte Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors Cancer Res 57 1997 1502 1509
22. M. Toda, S.D. Rabkin, and R.L. Marzuza Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1 Hum Gene Ther 9 1998 2177 2185
23. S.J. Advani, G.S. Sibley, and P.Y. Song Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors Gene Ther 5 1998 160 165
24. S.J. Advani, S.M. Chung, and S.Y. Yan Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resisitant experimental human tumors Cancer Res 59 1999 2055 2058
25. S.F. Stanziale, H. Peterowsky, and J.K. Joe Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase Surgery 132 2002 353 359
26. S.V. Blank, S.C. Rubin, and G. Coukos Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation Hum Gene Ther 13 2002 627 639
27. T.J. Jorgensen, S. Katz, and E.K. Wittmack Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer Neoplasia 3 2001 451 456
28. S. Kenny, and J.S. Pagano Viruses as oncolytic agents: a new age for 'therapeutic viruses?' J Natl Cancer Inst 86 1994 1185 1186